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Diuretics are used widely to raise renal salt and water
clearance in a variety of conditions, such as oedema, as
well in non-edematous states such as hypertension, which
can reduce morbidity and mortality of cardiovascular and
cerebrovascular diseases, especially the frequency of stroke
and congestive heart failure. However, long-term use of
conventional diuretics has several adverse effects including
electrolyte disorders, hyperuricemia, hyperlipidemia, and
glucose tolerance decrease. Electrolyte abnormalities can
induce cardiac arrythmias and sudden death. Therefore,
discovering a new diuretic that does not cause electrolyte
disturbance becomes a hot issue. Phenotype analysis of
knockout mice lacking urea transporter UT-B or various
UT-A isoforms has provided evidence for the involvement
of UTs in the urinary concentrating mechanism. Func-
tional deletion of UT-B or UT-A isoforms markedly
caused polyuria and urea selective low urine concentrating
ability. However, deletion of UT-B or UT-As did not affect
GFR and clearance rate of the principal solutes (Na+, K+,
Cl-) in urine except for urea. Therefore, we suggested a
hypothesis that UT inhibitors might be novel diuretics to
excrete water without disturbing electrolyte metabolism.
Present study discovered a potent small-molecular urea
transporter inhibitor, UT-A4, using an erythrocyte osmo-
tic lysis assay. Stopped flow light scattering experiment, a
classical assay for measuring water and urea permeability,
confirmed that UT-A4 reversibly inhibited UT-B activity.
The experiments also showed that UT-A4 targeted the
intracellular part of UT-B protein and had the same inhi-
bition activity on influx and efflux of urea across mem-
brane. UTinh-14 has inhibition activity on human, rabbit,
rat and mouse UT-B. We used rats as an in vivo test
model for determining the diuretic activity of UT-A4.
Interestingly, UT-A4 caused dose-dependent polyuria, low
urinary osmolality and urea concentration in rats. 18-h
water deprivation raised urine concentrating ability in rats
with or without UT-A4 treatment. However, urine osmol-
ality and urea concentration remained significantly less in
UT-A4 treated rats than that in control rats, except of
unchanged non-urea solutes. Osmolality and urea concen-
tration was significantly decreased in inner medullary tis-
sue of UTinh-14 treated rats, but not in HCTZ treated rats.
All these results suggest that UTinh-14 caused urea selec-
tive diuresis.
The excretion of osmoles, urea and non-urea solutes had
no significant difference between control and UTinh-14
treated rats. However, HCTZ treated rats had significant
higher excretion of osmole and non-urea solutes than con-
trol and UTinh-14 treated rats, which made lower blood
Na+, K+ and Cl-. These results indicate that UT-A4 is a
selective UT inhibitor and has urea selective diuretic activ-
ity without disturbing excretion of electrolytes. It might
have potential value on drug discovery as a new diuretic
without electrolyte imbalance and metabolic disorder. It
might also be used as a tool drug to study the physiologi-
cal roles of UTs in big animal models.
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